Orthofix Medical Plunges 23.86% Ahead of Earnings Report

On May 6, 2025, Orthofix Medical experienced a significant drop of 23.86% in pre-market trading, marking a notable decline in its stock performance.

Orthofix Medical Inc. is scheduled to release its Q1 2025 earnings report on May 6, 2025. The consensus estimate for Q1 2025 revenue is $191.10 million. This earnings report is anticipated to provide insights into the company's financial health and operational performance, which could influence investor sentiment and stock price movements.

Orthofix Medical is expected to announce its Q1 2025 quarterly earnings results before the market opens on Tuesday, May 6th. This announcement is crucial as it will offer a comprehensive view of the company's financial performance for the quarter, including revenue, earnings per share, and other key metrics.

AYAL Capital Advisors Ltd recently sold 115,635 shares of Orthofix Medical, which could indicate a shift in investment strategy or a change in market outlook for the company. This transaction may have contributed to the recent volatility in Orthofix Medical's stock price.

Shares of Orthofix Medical Inc. opened at $13.79 on Monday. The company has a market cap of $538.11 million, a price-to-earnings ratio of -4.41, and a beta of 0.87. These financial metrics provide a snapshot of the company's valuation and risk profile, which are important considerations for investors.